Alzheimers disease, mild cognitive impairment
Conditions
Interventions
effort and time for manupilation of a tablet
Sponsors
Takechi Hajime
Life Science Institute Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subjects who sign an informed consent 2. subjects who can manipulate a tablet 3. outpatient and medication are not asked. 4. A statistically significant difference is not observed in terms of things like an age between groups. (1) Alzheimers disease - Subjects who are diagnosed with diagnostic guidelines for Alzheimers disease from the National Institute on Aging-Alzheimers Association workgroups where assessment for decline of cognitive function is carried out with the ADNI criteria. - Subjects who are certainly diagnosed after first visit. (2) mild cognitive impairment - Subjects who are diagnosed with diagnostic guidelines mild cognitive impairment due to Alzheimers disease from the National Institute on Aging-Alzheimers Association workgroups where assessment for decline of cognitive function is carried out with the ADNI criteria. - Subjects who are certainly diagnosed after first visit. (3) healthy volunteer - Subjects who are finally diagnosed to be healthy after assessment. - Subjects who accompany outpatients.
Exclusion criteria
Exclusion criteria: - Subjects with psychiatric disorders like major depression disorder, bipolar disorder, epilepsy or schizophrenia - Subjects who may have epilepsy or photosensitivity by light stimulation - Subjects who are judged to be unacceptable by medical doctors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Accuracy and response time at each task of A-003 | — |
Secondary
| Measure | Time frame |
|---|---|
| - Total time for completion of A-003 - Comparison and correlation of each task of A-003 with neurophycological tests - Discrimination ability of A-003 among groups (sensitivity/specificity, AUC of ROC curve) | — |
Contacts
Public ContactHajime Takechi
Fujita Health University Hospital
Outcome results
None listed